The Vent Multiplexor is a patent-pending emergency co-ventilation device intended to provide individualized temporary rescue mechanical ventilation during the COVID-19 pandemic. Developed in collaboration with Yale-New Haven Hospital and granted Emergency Use Authorization by the FDA on April 15, 2020, the Vent Multiplexor has the potential to help reduce the clinical need for ventilators during the COVID-19 pandemic, as it permits the emergency sharing of ventilators between two patients who are not equally matched, by delivering individualized tidal volumes, while also providing critical validation data on the quality of patient matching using existing “T-connector” and similar ventilator splitting technologies, a potentially revolutionary paradigm shift in the delivery of pandemic emergency respiratory care.
NEWS
Vent Multiplexor Receives FDA Emergency Use Authorization for Crisis Care Co-Ventilation During COVID-19 Pandemic
Emergency rescue device developed
by Vent Multiplexor LLC in collaboration with Yale New Haven Hospital is the first ever device designed to enable individualized ventilation care for two patients sharing a single mechanical ventilator.
Immediate distribution of Vent Multiplexor to hospitals across the country and around the world planned.....
Vent Multiplexor Successfully Deployed at Yale New Haven Hospital for Crisis Care Co-Ventilation During COVID-19 Pandemic.
Vent Multiplexor Successfully Deployed at Yale New Haven Hospital for Crisis Care Co-Ventilation During COVID-19 Pandemic. Emergency device developed by Vent Multiplexor LLC in collaboration with Yale New Haven Hospital is the first ever device designed to provide temporary dual patient rescue mechanical...
Vent Multiplexor Clinical Use
In a recent peer-reviewed journal article, authors from Yale New Haven Hospital described successful use of the Vent Multiplexor in a clinical setting during the COVID-19 pandemic.